These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1107 related articles for article (PubMed ID: 568919)

  • 21. [Influence of chalones on the efficiency of cytostatics on the malignant melanoma (author's transl)].
    Fiedler H; Wohlrab W; Zaumseil RP
    Dermatol Monatsschr; 1979 Mar; 165(3):198-201. PubMed ID: 157300
    [No Abstract]   [Full Text] [Related]  

  • 22. A combination of photodynamic therapy and chemotherapy displays a differential cytotoxic effect on human metastatic melanoma cells.
    Biteghe FN; Davids LM
    J Photochem Photobiol B; 2017 Jan; 166():18-27. PubMed ID: 27852006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictability of response to clinical thermochemotherapy by the clonogenic assay.
    Mann BD; Storm FK; Morton DL; Bertelsen CA; Korn EL; Kaiser LR; Kern DH
    Cancer; 1983 Oct; 52(8):1389-94. PubMed ID: 6616404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanoma.
    Hardy KM; Strizzi L; Margaryan NV; Gupta K; Murphy GF; Scolyer RA; Hendrix MJ
    Mol Cancer Res; 2015 Apr; 13(4):670-80. PubMed ID: 25767211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a "nude" mouse-human tumor panel as a predictive secondary screen for cancer chemotherapeutic agents.
    Bellet RE; Danna V; Mastrangelo MJ; Berd D
    J Natl Cancer Inst; 1979 Nov; 63(5):1185-8. PubMed ID: 91697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor effects of L-glutamic acid dihydroxyanilides against experimental melanoma.
    Wick MM; Rosowsky A; Ratliff J
    J Invest Dermatol; 1980 Feb; 74(2):112-4. PubMed ID: 6766171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and characterization of two canine melanoma cell lines: new models for comparative oncology.
    Segaoula Z; Primot A; Lepretre F; Hedan B; Bouchaert E; Minier K; Marescaux L; Serres F; Galiègue-Zouitina S; André C; Quesnel B; Thuru X; Tierny D
    BMC Cancer; 2018 Dec; 18(1):1219. PubMed ID: 30514258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental chemotherapy of murine melanomas: is there a discrepancy compared to clinical experience?
    Borovanský J
    Neoplasma; 1997; 44(5):277-81. PubMed ID: 9473785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model.
    Mathieu V; Le Mercier M; De Neve N; Sauvage S; Gras T; Roland I; Lefranc F; Kiss R
    J Invest Dermatol; 2007 Oct; 127(10):2399-410. PubMed ID: 17495956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of certain chemopreparations on transplantable strains of human tumors, melanoma and Ewing sarcoma, obtained from tissue cultures].
    Revazova ES
    Vestn Akad Med Nauk SSSR; 1980; (12):81-4. PubMed ID: 7257580
    [No Abstract]   [Full Text] [Related]  

  • 31. Relation of in vitro colony survival to clinical response in a prospective trial of single-agent chemotherapy for metastatic melanoma.
    Meyskens FL; Loescher L; Moon TE; Takasugi B; Salmon SE
    J Clin Oncol; 1984 Nov; 2(11):1223-8. PubMed ID: 6387058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity.
    Schadendorf D; Worm M; Algermissen B; Kohlmus CM; Czarnetzki BM
    Cancer; 1994 Jan; 73(1):103-8. PubMed ID: 7506115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro methods to complement in vivo approaches utilizing combinations of chemotherapy and immunotherapy.
    Sigel MM; Lichter W; Lopez DM
    Cancer Chemother Rep 2; 1974 Mar; 4(1):109-14. PubMed ID: 4133186
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute effects of two melanocytolytic agents, hydroquinone and beta-mercaptoethanolamine, upon tyrosinase activity and cyclic nucleotide levels in murine melanomas.
    Abramowitz J; Chavin W
    Chem Biol Interact; 1980 Oct; 32(1-2):195-208. PubMed ID: 6253089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
    O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J
    Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells.
    Belt JA
    Mol Pharmacol; 1983 Nov; 24(3):479-84. PubMed ID: 6314117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in drug sensitivity among tumor cells from parental tumors, selected variants, and spontaneous metastases.
    Tsuruo T; Fidler IJ
    Cancer Res; 1981 Aug; 41(8):3058-64. PubMed ID: 7248962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro and in-vivo inhibition of melanoma growth and metastasis by the drug combination of celecoxib and dacarbazine.
    Sadhu SS; Wang S; Averineni RK; Seefeldt T; Yang Y; Guan X
    Melanoma Res; 2016 Dec; 26(6):572-579. PubMed ID: 27540834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human tumor models in the severe combined immune deficient (scid) mouse.
    Paine-Murrieta GD; Taylor CW; Curtis RA; Lopez MH; Dorr RT; Johnson CS; Funk CY; Thompson F; Hersh EM
    Cancer Chemother Pharmacol; 1997; 40(3):209-14. PubMed ID: 9219503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetic aids to proper chemotherapeutic scheduling: labeled nucleoside incorporation studies in vivo.
    Young RC
    Cancer Treat Rep; 1976 Dec; 60(12):1947-58. PubMed ID: 1026349
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.